report adjust ep consensu
expect in-lin estim compani adjust
oper margin quit high anticip lower-than-
anticip tax rate provid off-set
million slightli consensu expect
million similar forecast million adjust
result adopt account standard codif
lower report revenu adjust sg expens
approxim million revenu growth would
exclud acquisit chang foreign currenc exchang rate syk
sale improv organ similar forecast led
strength neurotechnolog spine organ medsurg
equip organ compani hip knee implant sale
also consist forecast
adjust result adopt adjust
oper margin improv roughli bp year-over-year
higher end target rang year forecast
expect stronger year-over-year growth given easi comp
bp year-over-year caus primarili two product suppli
issu product
follow rel strong rais outlook organ
growth high end prior rang addit compani
increas adjust ep guidanc versu
consensu expect
reiter expect achiev long-term financi target
includ floor adjust ep growth despit expect dilut
definit agreement acquir group
rais adjust ep estim
respect primarili reflect higher organ growth
syk revenu slightli consensu expect
compani organ growth remain strong manag commentari
regard outlook variou busi segment includ strong order
backlog medsurg equip divis exit remain favor
rais forecast effort better reflect momentum
busi remain posit long-term outlook
maintain buy rate rais price target
import pleas read disclosur disclaim page report
total debt total asset
report adjust ep consensu expect in-lin
estim compani adjust oper margin quit high anticip lower-than-
anticip tax rate provid off-set
report basi syk revenu increas year-over-year million slightli
consensu expect million similar forecast million adjust
result adopt account standard codif lower report
revenu adjust sg expens approxim million revenu growth would
exclud acquisit chang foreign currenc exchang rate syk sale improv
organ similar forecast
stryker adjust incom statement analysisnorthcoast research million except percentag per share sg interest incom incom margin incom compani report northcoast research estim factset result reflect adopt account standard codif lower report revenu adjust sg expens million
divis standpoint strong result syk medsurg equip neurotechnolog spine busi
help off-set weak trauma/extrem orthoped product asid hip knee
implant lead organ growth in-lin estim
medsurg equip achiev organ growth forecast
quarter result strong across divis four segment led low-double-digit organ growth
instrument high-single-digit organ growth endoscopi medic sustain solut similar
recent quarter instrument led power surgic instrument roll-out medic
benefit significantli easi comp product total contribut roughli bp medic
organ growth quarter remaind segment face strong double-digit growth comparison
quarter notabl point strength medsurg equip backlog exit aid
result compani also expect benefit start next year roll-out high
definit camera system endoscopi
stryker corporationtot compani organ growth analysi two fewer sale day year-over-year one extra sale day year-over-year one fewer sale day year-over-year compani report corpor organ growth analysiscategorynorthcoastreportedtot compani organ orthoped medsurg equip neurotechnolog spine compani report northcoast research estim
neurotechnolog spine product achiev organ growth
forecast similar recent quarter neurotechnolog sale except strong roughli
organ exclud entellu acquisit led neurovascular neuro power instrument cmf
product sale growth also remain low-double-digit rang organ similar last quarter syk spine
organ growth remain posit exclud vexim acquisit aid improv market condit new
orthoped product syk sale increas organ estim
quarter hip knee implant sale consist forecast howev trauma extrem
organ growth deceler organ growth versu high-single-digit compani attribut
market weak product suppli issu expect resolv addit organ
growth orthoped product rel weak organ mako robot surgeri system
placement increas
stryker corporationmedsurg equip organ growth analysi two fewer sale day year-over-year one extra sale day year-over-year one fewer sale day year-over-yearsourc compani report corporationneurotechnolog spine organ growth analysissourc compani report two fewer sale day year-over-year one extra sale day year-over-year one fewer sale day
knee implant achiev organ growth slightli forecast
quarter syk knee implant organ growth organ benefit modestli stronger market
well increas demand cementless triathlon tritanium knee system addit mako system sale
competit account increas surgeon train mako total knee implant applic roughli
versu approxim syk earn call total case perform
syk mako total knee despit typic softer summer surgeri schedul
hip implant achiev organ growth slightli forecast in-lin
modestli market rate overal encourag syk hip result particularli given focu
key differenti knee mako total knee applic cementless knee offer within orthoped divis
stryker corporationworldwid knee implant organ growth analysi two fewer sale day year-over-year one extra sale day year-over-year one fewer sale day year-over-yearsourc compani report corporationworldwid hip implant organ growth analysi two fewer sale day year-over-year one extra sale day year-over-year one fewer sale day year-over-yearsourc compani report adjust result adopt adjust oper margin improv roughli
bp year-over-year higher end target rang year
forecast notabl expect stronger year-over-year growth given easi comp bp year-over-
year caus primarili two product suppli issu product price growth
year-over-year versu year-over-year headwind also slightli higher
increment headwind quarter although remain neg rang compani
follow rel strong rais outlook organ growth high end prior
rang addit compani increas adjust ep guidanc versu
consensu expect also reiter expect achiev long-term financi target
includ floor adjust ep growth despit expect dilut definit agreement
rais adjust ep estim respect
primarili reflect higher organ growth assumpt
overal syk revenu slightli consensu expect compani organ growth
remain strong manag commentari regard outlook variou busi segment
includ strong order backlog medsurg equip divis exit remain favor
rais forecast effort better reflect momentum busi remain posit
long-term outlook maintain buy rate rais price target
stryker corporationannu incom statement analysi adjust northcoast research million except percentag per share gross gross sg intang oper oper net interest incom incom tax incom extra incom extra extra net net wghd com share ep ep growth ep growth start exclud acquistion-rel intang amort expens adjust ep compani report northcoast research estim disclosur
